The Gateway is a single portal to manage licenses, permits, and registrations with the North Carolina Board of Pharmacy. Access printable documents, update information, submit applications, and more.
Click Here
Details about these new plans may be found here. Questions about these new plans should be directed to North Carolina Medicaid.
Please report any broken links or other navigation issues to us at info@ncbop.org or call us anytime.
Read MoreThe NCBOP and NCPHP established the L. Stanley Haywood Recovery Fund in 2018. It provides financial support to qualifying pharmacy personnel in need of substance use assessment, treatment, and monitoring services. Learn more about donating or applying for assistance.
Read MoreProhibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act.
Read MoreCurrent Board President Andy Bowman announced last month his departure from Board service, leaving a vacancy for the Southeastern District position. Applicants wishing to be considered to fill this vacancy may read more below.
Read MoreA public hearing will be held at 9:30AM on Tuesday, July 9, 2024 at the Board’s office to consider these changes.
Read MoreOptometrists who dispense certain prescription drugs may now register with the Board of Pharmacy. The initial registration fee is $75 and requires an annual renewal.
Read More
Board meetings are live-streamed and past meetings are archived here.
JUNE 18, 2024
Details about these new plans may be found here. Questions about these new plans should be directed to North Carolina Medicaid.
june 7, 2024
NCBOP members and staff are pleased to share our updated website! The URL – www.ncbop.org – remains the same, but you will see improvements to the site including a cleaner, more user-friendly interface; reorganized and more easily searchable frequently asked questions (FAQs) sections; and modules for each type of license, permit, and registration that the Board issues. Please contact us if you have questions or trouble finding information.
JUNE 29, 2023
On June 27, 2023 the federal Food and Drug Administration (“FDA”) issued a draft guidance document titled “Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act.” Section 503B states that an outsourcing facility is not eligible for the statutory exemptions for its compounded product if the product is sold or transferred by an “entity other than the outsourcing facility that compounded such drug.” Board staff have received calls from time to time inquiring whether this provision prohibits pharmacies from purchasing a compounded prescription product from a 503B outsourcing facility and then dispensing it to a patient pursuant to an individual patient prescription. FDA’s draft guidance states, among other things, that the following situations would not be subject to Section 503B’s wholesaling prohibition:
* An outsourcing facility distributes a drug it compounded (without obtaining a patient-specific prescription) to a health care professional who administers it in a health care setting (e.g., in a hospital or the physician’s office)
* An outsourcing facility distributes a drug it compounded (without obtaining a patient-specific prescription) to a hospital or health system, health clinic, or physician’s office, and it is administered within that hospital or health system, health clinic, or physician’s office.
* An outsourcing facility distributes a drug it compounded (without obtaining a patient-specific prescription) to a hospital or health system, health clinic, or physician’s office where it is used as office stock to dispense to patients pursuant to prescriptions.
* An outsourcing facility distributes a drug it compounded to a state-licensed pharmacy, federal facility, or licensing physician, which subsequently dispenses the drug pursuant to a prescription.
The draft guidance is found here: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/prohibition-wholesaling-under-section-503b-federal-food-drug-and-cosmetic-act. The title page of the draft guidance contains instructions to submit comments and suggestions within 60 days.
FEBRUARY 27, 2024
Optometrists may now register with the NC Board of Pharmacy to dispense certain prescription drugs. G.S. § 90-127.4. Dispensing optometrists may dispense prescription drugs to their own patients only for the diagnosis and treatment of abnormal conditions of the eye and its adnexa. G.S. § 90-127.4(a) & (c). Dispensing optometrists may not compound medications, nor may they dispense controlled substances. G.S. § 90-127.4(a).
Dispensing optometrists must register with the Board of Pharmacy prior to beginning dispensing activities and must renew that registration annually. G.S. § 90-85.26B. The initial registration fee is $75, as is the annual renewal fee. G.S. § 90-85.24(a)(20).
A dispensing optometrist must comply in all respects with relevant laws and regulations that apply to pharmacists governing the distribution of drugs, including packaging, labeling, and record keeping. G.S. § 90-85.26B. The Board of Pharmacy may discipline a dispensing optometrist’s registration for violation of these laws and regulations. The Board of Optometry may discipline an optometrist’s license to practice optometry. G.S. § 90-85.25B.
Step-by-step instructions for completing a dispensing optometrist registration are found here.
MARCH 11, 2024
Today (March 11, 2024), NC DHHS issued an updated COVID-19 treatment provider memo. Included in this memo is a reminder that EUA-labeled Paxlovid is no longer authorized for use, information about PAXCESS – a program that can help patients with financial barriers obtain Paxlovid, an update on clinical data on the efficacy of antiviral treatments, and a note on the large portion of the North Carolina population considered high risk based on age or health conditions. The memo is found here.